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ABSTRACT 
POSTPARTUM CONTRACEPTION AND RAPID REPEAT PREGNANCIES IN RURAL, 
LOW-INCOME BLACK WOMEN WITH BASELINE RISK FACTOR COMPARISONS 
By 
KAREN LI 
July 27, 2015 
 
INTRODUCTION:  The residents in the Low Country region of South Carolina consist of a 
predominantly low-income, African American population with a history of trauma and 
experiences of racism. Chronic conditions, unintended pregnancies, and adverse birth outcomes 
are prevalent. Many women experience rapid repeat pregnancies (RRP) due to lack of access to 
choices in contraceptive methods or lack of education on the dangers of RRP and prevention 
through contraception. Low Country Healthy Start (LCHS) aims to ensure that perinatal women 
and adolescents in the service area who enrolled received adequate prenatal and postpartum care, 
educational and counseling services, and contraceptive methods, including a Depo Provera 
injection at discharge (D1) after their index birth in LCHS. Previous research agree that black 
women, adolescents, low education, mental health, and past trauma are all associated with RRP, 
and lack adolescents are less likely to retain a form of contraception that requires maintenance 
and proper usage. 
 
AIM: To (1) examine the effect of D1 and other variables on time to RRP; and to (2) examine 
the effect of receiving various forms of contraception and their use over time, including the Depo 
injection (D2) on time to RRP. 
 
METHODS: Clients included in the analysis either delivered a baby while enrolled in LCHS or 
had complete data on all necessary variables (n=761). The Cox regression model was fitted to 
model the effect of receiving different contraceptive methods as well as relevant and statistically 
significant (α=0.05) risk factors on time to RRP.  
 
RESULTS: For Aim 1, D1 resulted in a hazard rate about 46% lower than that of a non-D1 
(unadjusted HR = 0.54, 95% CI: 0.36- 0.83; adjusted HR = 0.52, 95% CI: 0.34-0.8). However, 
after adjusting for other variables (age, unplanned index pregnancy, physical abuse during 
pregnancy, and postpartum depression score) and the time-varying effect of D1, D1 resulted in a 
HR of 29.63 (β = 3.39, 95% CI: 6.049- 145.141), that decreased at a natural log function of time 
(HR = 0.22, β = -1.53, 95% CI: 0.12-0.40). 
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For Aim 2, D2 resulted in a lower hazard rate than non-D2 (unadjusted HR = 0.17, 95% CI: 
0.09-0.32; adjusted HR = 0.16, 95% CI: 0.08-0.31). Adjusting all variables in Aim 2, including 
D2, D1 resulted in a statistically insignificant lower HR of 0.88 (p = 0.544, 95% CI: 0.57-1.34). 
There was no significant interaction between D1and D2 or between D1 and any other 
contraceptive type. LARC showed a highly protective but not statistically significant effect 
against RRP (adjusted HR = 0.05, p = 0.093, 95% CI: 0.002-2.26), but that protective effect 
decreased multiplicatively by about .25 with each passing month (HR = 1.25, p = 0.029, 95% CI: 
1.02-1.53). 
 
DISCUSSION: These findings indicate that the Depo injection, although important to receive at 
discharge, must be continued consistently to have a significant protective effect in preventing a 
RRP. LARC methods in general are strong protective factors. Being issued a contraceptive 
method that required adherence predicted a shorter inter-pregnancy interval (IPI), but this 
reflects the client’s adherence to the contraceptive method, and not its biological effectiveness. 
Future research should examine the effect of receiving the Depo injection at discharge on the 
continuation of different contraceptive methods, as well as the effect of counseling and 
educational services on contraceptive use and time to RRP. 
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Introduction 
1.1 Background 
Rapid repeat pregnancies (RRP), defined by medical and social science journals as 
subsequent pregnancies in which the time period from birth of the index child to next conception, 
or the inter-pregnancy interval (IPI), are either less than 24 months (Barnet et al., 2009; 
Crittenden et al., 2009; Damle et al., 2015; L Patchen et al., 2009; L Patchen et al., 2009; Raneri 
& Wiemann, 2007), 18 months (Gemmill & Lindberg, 2013; Gillmore et al., 1997; Waggoner et 
al., 2012), 12 months (Bennett et al., 2006; Templeman et al., 2000; Tocce et al., 2012), or 
sometimes 6 months (Patchen & Lanzi, 2013). They are a major public health issue, especially 
for populations that have a high rate of poverty, low education, chronic conditions, and 
adolescent pregnancy. Adolescent pregnancy presents an enormous responsibility that the girl 
and her family cannot afford, disrupts her educational path, and pulls her even deeper into a life 
in poverty. Lack of knowledge or access to effective prevention methods and other personal 
obstacles or influences perpetuate perceptions and behaviors, putting girls and women at higher 
risk of a shorter IPI (Bennett et al., 2006; Crittenden et al., 2009; Gemmill & Lindberg, 2013; 
Gillmore et al., 1997; R. Gold et al., 2004; James-Hawkins & Sennott, 2015; L Patchen et al., 
2009; Patchen & Lanzi, 2013; Raneri & Wiemann, 2007). After delivery, for example, a woman 
who resumes intercourse, while neither breastfeeding nor using an effective method of 
contraception, is at risk of pregnancy within three weeks regardless of next menses (Sober & 
Schreiber, 2014; Tepper et al., 2011). 
 The Low Country region of South Carolina consists of a predominantly black, low-
income, rural population. The inhabitants face a lifetime of economic hardships, psychological 
stressors, chronic conditions, and infant morbidity and mortality. One birthing hospital serves all 
Postpartum Contraception and Rapid Repeat Pregnancies11 
 
four counties in Low Country: Allendale, Bamberg, Hampton, and Orangeburg. Financial 
barriers to health care hinder the ability for women to obtain effective contraception and 
knowledge of, leading to negative outcomes of great magnitude, both direct and indirect, for both 
infant and maternal health. Other issues that are prevalent in the population, such as adolescent 
pregnancy, easily exacerbate the conditions.  
1.2 Purpose 
In 2007, the Low Country Healthy Start program (LCHS) was implemented as an effort 
to improve all aspects of perinatal and family health, including family planning and pregnancy 
spacing, for women (clients) who enroll in the program. Several benchmarks are set at the 
federal level with target figures. For example, Healthy Start aims to promote quality by reducing 
the proportion of Healthy Start pregnancies conceived within 18 months of a previous birth to 
30%. Services include counseling about effective contraceptive choices in the prenatal and 
postpartum period. LCHS collaborates with doctors and midwives to offer the Depo Provera 
injection to each client upon discharge from the hospital after giving birth. Client navigators 
(CNs) coach clients individually to ask for the Depo injection if not offered. In 2012, 59.4% of 
enrolled women left the hospital after delivery with an effective contraceptive method, up from 
43.9% in 2003. Even with the extensive measures that the program takes, at least 40% were not 
offered, declined, or did not ask for the Depo injection. Such cases require comprehensive 
casework to assess these clients for influential factors such as intent of pregnancy, intent to 
breastfeed, perceptions of contraceptive methods and of carrying a baby, and behavioral and 
social influences.  Overcoming current challenges requires thorough coordination and 
communication between case managers, LCHS personnel, and health providers. 
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Barriers still exist that prevent adequate knowledge about the inter-pregnancy period 
from being disseminated effectively in regions such as Low Country. For a population that is 
prone to RRP in the midst of perpetual economic hardship, LCHS must ascertain the factors that 
lead to RRP in order to help women with family planning, including effective contraceptive use, 
to achieve longer IPIs. This study has two primary aims: (1) to evaluate the effect of receiving 
the Depo injection at discharge on time to subsequent pregnancy, accounting for other risk 
factors and potential confounders, and (2) to investigate the effect of receiving Depo injections 
over time on time to RRP, relative to using other contraceptive methods over time. We believe 
that receiving the Depo injection at discharge will be a protective factor against shorter IPIs. 
Secondly, we believe that receiving Depo injections over time or receiving a long-acting 
reversible contraceptive (LARC) during the postpartum period will also protect against shorter 
IPIs. Separate analyses will be done to accomplish Aim 1 and Aim 2.  
Literature Review 
 The literature that was selected in relevance to this study presents past research on 
predictors of short IPIs among at-risk and marginalized women. First, we discuss both 
demographic factors and pregnancy-related factors that have been shown to lead RRPs, including 
African American race and adolescence. Pregnancy-related factors include characteristics such 
as mental health, intention of pregnancy, and behavioral tendencies. Next, we present evidence 
of factors that influence the choice of a postpartum contraceptive method. Whether or not a 
woman should use postpartum contraception and which one heavily depends on both health risks 
and the woman’s behavior and lifestyle postpartum (i.e. breastfeeding, resuming sexual 
intercourse). Furthermore, whether or not a woman actually takes the contraceptive method and 
continues it may depend on several psychological and behavioral factors. Finally, the literature 
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discusses how different methods of contraceptives actually affect IPIs in the presence of 
characteristics of women similar to the Low Country population.  
2.1 Characteristics That Lead to Short Inter-pregnancy Intervals (IPI) 
Gemmill and Lindberg (2013) conducted a cross-sectional study on a nationally 
representative sample (n = 2,253) of self-reported subsequent pregnancies in the US. They found 
that 35% of the pregnancies were conceived within 18 months of a previous birth. Black women, 
15-19 year old adolescents, and women reporting an unintended pregnancy were significantly 
more likely to experience a RRP. Use of contraceptive method was not included in the study, but 
women who had a Medicaid delivery were more likely to report the pregnancy as unintended.  
The CDC Morbidity and Mortality Weekly Report (MMWR) stated that, out of over 
367,000 adolescent (15-19 years old) births from 16 Pregnancy Risk Assessment Monitoring 
System (PRAMS) sites across the US (15 states and New York City) from 2007-2010, almost 
20% were repeat births (Gavin et al., 2013). This report similarly found that black adolescents 
are more likely than white adolescents and Hispanic adolescents to experience a rapid repeat 
pregnancy (Gavin et al., 2013; Gemmill & Lindberg, 2013).  
Crittenden et al. (2009) looked at self-reported mental health factors, behavioral factors, 
and past experiences that led to RRP (< 24 months) in a sample of mostly black adolescents (n = 
354). Baseline reports of later age at menarche and a greater likelihood of physical aggression 
were associated with RRP. James-Hawkins and Sennot (2015) performed a qualitative study that 
consisted of narratives describing 30-60 minute interview sessions with 40 low-income women, 
20 black and 20 white, and their child-bearing experiences throughout their life course. The 
narratives exhibit trends of self-claimed young naiveté in instances of adolescent pregnancy, 
hyper-fertility (failure of contraceptive methods), and inclination toward mainstream social 
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norms (i.e. having one’s first baby at an appropriate age) even if they themselves violated them 
(“young and dumb”). They reveal common perceptions among low-income women in that they 
would prefer to wait to have children, and that they often felt that their pregnancies were beyond 
their control or due to youthful lack of education on the matter. Although the more recent studies 
of factors of RRP lack a large sample size and high quality methodology or analysis, the findings 
support associations of the above important characteristics that need to be examined further, 
more rigorously, and in the context of contraceptive practice.  
Patchen et al. (2009) conducted a preliminary study (n = 58, 59% black) with prevalence 
estimates of mental health and trauma indicators in adolescent mothers who had a subsequent 
pregnancy (SP) within 24 months and adolescent mothers who did not (NSP, comparison group: 
random sample of the NSPs, matched for age and ethnicity). In this small sample, significantly 
more SP adolescent mothers than NSP adolescent mothers had recorded mental health issues 
(from discouragement to attempting suicide) and trauma (rape, physical or emotional abuse, 
sexual abuse, or death of a loved one) in their prenatal and postpartum assessments. They 
conducted another study (n = 279) on maternal depression and RRP (< 6 months) in first-time 
mothers (ages 15-36 years) and found that women diagnosed with moderate to severe depression 
had significantly higher odds (7.24) of RRP than women diagnosed with minimal to mild 
depression (Patchen et al., 2013). However, the comparison was based on a small outcome of 12 
RRPs. Although the study began with a small sample size and experienced a high attrition rate, 
the follow-up period lasted 36 months with a RRP cutoff at 6 months. They reported no 
significant difference between races, although their only indicators were white and non-white. 
Studies using older data from the early 1990s to determine social and socioeconomic 
factors, while disregarding use of contraceptives, either found no difference in time to RRP 
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(Gillmore et al., 1997; Gold et al., 2004, 2005) or occurrence of RRP  (Raneri & Wiemann, 
2007) between different races, or their samples consisted mostly of white women (Gillmore et 
al., 1997). This could be an indication of the influence of welfare reform, since the results of the 
studies are more consistent within time periods (Raneri & Wiemann, 2007). All studies found on 
the matter agree that adolescent mothers are at high risk of RRP (Crittenden et al., 2009; Damle 
et al., 2015; Gavin et al., 2013; Gemmill & Lindberg, 2013; Patchen & Lanzi, 2013; Raneri & 
Wiemann, 2007; Sober & Schreiber, 2014; Templeman et al., 2000; Tocce et al., 2012; 
Waggoner et al., 2012). 
2.2 Postpartum Contraceptive Methods 
There are many important considerations in choice of contraceptive method that, in turn, 
require a variety of choices in order to ensure mother and infant health and adequate pregnancy 
spacing (Sober & Schreiber, 2014). In terms of safety, the CDC’s US Medical Eligibility Criteria 
for Contraceptive Use (2011) revised recommendations for postpartum contraceptive methods 
include specific timelines of safe usage for breastfeeding versus non-breastfeeding women, as 
well as for women at risk of venous thrombosis (VT). Sober and Schreiber (2014) reviewed the 
different methods, considerations and processes that postpartum mothers should adhere to for 
health, safety and prevention. A postpartum woman’s plan to breastfeed is a critical decision that 
affects both her choices in postpartum contraceptive methods as well as her chances of 
experiencing a short IPI. If she chooses to breastfeed, she must use either a non-hormonal form 
of contraception or a progestin-only form in order to avoid affecting the breast milk or the infant. 
While breastfeeding and depending on the frequency and duration, a postpartum woman will 
experience lactation amenorrhea (LAM), in which her resumed ovulation will be delayed. 
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However, for LAM to be achieved, the postpartum mother must be breastfeeding exclusively and 
less than 6 months postpartum. 
Other factors that influence a woman’s choice of contraceptive method, and the 
continued use, are insurance coverage, perinatal counseling and health services, and types of 
contraception that are made available and accessible (Gavin et al., 2013; Miller et al., 2000; 
O’Neil-Callahan et al., 2013; Tang et al., 2013). Influences within the woman’s life, including 
perceived barriers or effectiveness of contraceptive methods (James-Hawkins & Sennott, 2015; 
Miller et al., 2000) and psychological, social, and behavioral factors also show potential to 
predict both postpartum contraception use and RRP (Bennett et al., 2006; Tang et al., 2013; 
Templeman et al., 2000; Waggoner et al., 2012). Miller et al. (2000) examined postpartum 
contraceptive choices among a sample of mostly single, black women who were eligible for 
Medicaid (n = 299). The main risk factor was the baseline prenatal perception of each method as 
“Most Effective,” “Safest,” or “Best for [Her].” Due to resource restrictions, the study was only 
able to include the OCP, DMPA, condoms, and tubal ligation. The study found a low rate of 
consistent use postpartum among women who chose OCP (54.7%) and among women who 
chose condoms (31.3%). The nature and results of this study reflect both the lack of choices and 
the indecision (due to lack of knowledge, lack of counseling, etc.) experienced among Medicaid-
eligible women.  
The MMWR (2013) reported that black adolescents were significantly less likely to use 
highly effective contraceptive methods postpartum (14.3%) than non-Hispanic white teens 
(24.6%) and Hispanic teens (27.9%). As discussed in Section 2.3, these statistics are likely to be 
closely related to the demographic population’s higher likelihood of RRP. Each study highlights 
the need for increased access as well as contraceptive education and counseling from the prenatal 
Postpartum Contraception and Rapid Repeat Pregnancies17 
 
period through the postpartum period, although with varying degrees of bias and contextual 
access to services. 
2.3 Postpartum Contraception Use and Rapid Repeat Pregnancies 
Adherence to non-LARCs, which require either daily or weekly maintenance, is prone to 
failure, so such methods are deemed by several publications to be less effective. A mixed race 
(61.2% black), multi-site study (n = 227) examined participant characteristics, 6-month 
contraception use, and RRP (< 18 months) among postpartum women aged 14-36 (Waggoner et 
al., 2012). Contraceptive choices were long-acting (sterilization, Norplant, implant, IUD, DMPA, 
or injectables) and others (OCP, condoms, diaphragm, patch, sponge, abstinence, withdrawal, 
etc.). The majority of the sample was black, but there were no significant differences between 
race and RRP. The study also found teens to be at significantly higher risk for RRP than adult 
women, controlling for education and ethnicity. Interestingly, a greater proportion of participants 
who had a goal-oriented intention for their next pregnancy (e.g. completing education) chose a 
long-acting contraceptive than participants who wanted never to have another pregnancy. 21.6% 
of the ‘never again’ patients were pregnant again within 18 months. Participants ages 14 to 16 
were over twice as likely to experience a RRP as adult women, and using a LARC at 6 months 
decreased risk of a RRP by 70% compared to using no method. 
Bennett et al. (2006) conducted a study (n = 643, 68.9% black, age ≥ 19) that considered 
low education as the main predictor of unintended rapid repeat pregnancies, while testing for 
mediating effects of depression and contraceptive method. They considered highly effective 
methods to be oral and transdermal hormonal contraception (always in use during intercourse), 
DMPA, and combination hormone contraception (used monthly). They found that education 
status had a strong effect on unintended RRP. Less effective methods were also associated with 
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unintended RRP, but neither contraceptive method nor depression mediated the effect of 
education. This study also found that 22.3% of the women breastfed at 3 months after delivery, 
with similar rates between education levels. By 11 months postpartum, however, 9.1% (7.1%) of 
high (low) education participants were still breastfeeding. Both studies that factored in 
postpartum contraception found that depression had no effect on rapid repeat pregnancy, which 
conflicts with studies mentioned earlier that did not consider contraceptive method. 
Damle et al. (2015) looked at contraceptive choices as factors of RRP (< 2 years) using 
data on adolescent mothers in a mostly black, Medicaid insured sample (n = 340). The available 
LARCs were LNG IUD, copper IUD, and subdermal implant, measured at initiation within 8 
weeks postpartum. DMPA injections were the only inpatient contraceptive method available. 
Other contraception indicators were ‘nothing documented,’ declined, condoms, OCP, patch and 
ring. Getting the DMPA injection before discharge resulted in significantly fewer RRPs than 
declining the injection. Use of LARCs and postpartum visits within 8 weeks also significantly 
reduced RRPs, but patients who reported intent to use LARC but had not yet initiated it by their 
postpartum visit had the same pregnancy rate as those who did not plan to use LARC. Notably, 
prenatal care, social worker involvement, and participation in a specialized teen pregnancy 
program were all insignificant in predicting RRP. Limitations included inadequate follow-up 
documentation and possible under-reporting of subsequent pregnancies. 
An older study (n = 206) compared RRP (< 12 months) in postpartum adolescents who 
delivered in 1997 and chose either the DMPA or OCP upon discharge (Templeman et al., 2000). 
Follow-up for updates on contraceptive use and pregnancy status lasted at least 12 months. 
DMPA users had almost twice the retention rate of OCP users, and OCP users were 9.09 times as 
likely to experience RRP. All three studies show significant reductions in RRP for LARC users 
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compared to non-LARC users. However, they used either logistic regression with longitudinal 
data or Kaplan Meier estimates to track contraceptive changes, so precise trends could not be 
captured. 
2.4 Interventions against RRP 
Barnet et al. (2009) conducted a randomized controlled trial and used a Cox proportional 
hazards model to examine the association between specialized counseling sessions and time to 
repeat pregnancy in a sample of mostly black, Medicaid insured adolescent mothers (n = 235). 
The computer-assisted motivational intervention (CAMI) was designed to prevent RRP in 
adolescents through quarterly sessions until 2 years postpartum and a single home visit. It used a 
trans-theoretical model that assessed sexual relationships, contraception-use intentions and 
behaviors, and readiness to engage in pregnancy prevention. CAMI+ also included a multi-
component home-based intervention and monthly visits, while the control group received 
standard usual care. The CAMI+ group resulted in a significantly lower rate of RRP than the 
control group, but the CAMI-only group did not. Completing at least 2 CAMI sessions in either 
CAMI group significantly reduced the rate of RRP. The study may have had issues with 
implementation fidelity: the CAMI+ group consisted of more interactive components, which 
likely ensured greater compliance. Participants who became pregnant during the trial were 
required to cease the intervention, because it used an algorithm that could not accommodate 
pregnancies. Still, the study highlights the benefit of frequent counseling. Depressive symptoms, 
drug use, and, notably, wanting another child within 2 years were all insignificantly associated 
with RRP. 
Finally, Patchen et al. (2013) sought to determine the effect of an integrated services 
program aimed at promoting contraceptive use and preventing subsequent pregnancies (< 24 
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months) among participants (n = 187, 61.3% black). The intervention was stratified by site: 
hospital-based health center (HHC, 89.8% black) or community-based health center (CHC, 
78.1% Hispanic). 43.9% of the HHC participants’ family received public assistance, and 50% of 
the HHC participants’ mother was a teen parent. HHC participants had a higher rate of 
graduation or GED, and both parents also had a higher rate of graduating from high school. The 
study only reported prevalence of contraceptive use and subsequent pregnancy among each site 
and their total.  In such an integrated services setting with free contraceptive counseling and 
issuance, rate of use decreases at a slow rate over time. Rates of both subsequent pregnancy and 
subsequent birth were higher in the CHC participants than the HHC participants. Major 
limitations to the study were a high attrition rate and lack of a comparison group. The 
comparisons between sites, however, provided a proximate indicator of race. Compared to CHC 
participants, HHC participants had a higher rate of RRP (21.1% vs. 16.4%).  
2.5 Summary 
According to the literature, the women of LCHS are in a demographic group that is more 
susceptible to a short IPI. The psychological stressors and trauma that they are more likely to 
experience, as found by Patchen et al. (2009), make them prone to depression. This study 
controls for physical abuse during the index pregnancy and postpartum depression. The literature 
presents evidence that black women with low socioeconomic status are at a higher risk of not 
using an effective form of contraception, and that postpartum adolescents who choose a Depo 
injection over OCP are more likely to continue use and prevent a RRP. Choosing a postpartum 
contraceptive method is a critical point in the stages of family planning that has been researched 
at length. Evidence indicate LARCs to be the most effective form of contraception when 
available, and that LARC and DMPA injections are the safest choice for women with risk of VT 
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and for women who plan to breastfeed. The OCP is highly effective (Bennett et al., 2006), but 
only when used correctly; research shows that it has a lower retention rate and a lower rate of 
proper maintenance and usage. This study will model time to RRP according to indicators related 
to the above risk factors. 
Methods 
3.1 Study Population 
Clients who enroll in LCHS are residents of the four counties that make up Low Country, 
South Carolina. The region consists of a predominantly black, low-income population with a 
history of chronic conditions and other hardships that perpetuate a prevalence of adverse birth 
outcomes for mothers and infants. Both pregnant women and mothers are accepted into LCHS, 
but the target population for this study is women and adolescents who either (1) entered LCHS 
with a pregnancy or (2) entered LCHS recently postpartum. At the time of the study, the number 
of clients enrolled in LCHS was 2,460. 2,259 clients were eligible for this study, with correctly 
entered data and sufficient records of index delivery (first delivery while enrolled in LCHS) and 
contraceptive method issuance. 
3.2 Low Country Healthy Start Program Strategy and Data Collection 
The program is an ongoing case management intervention, with a client navigator (CN) 
who works with each clients during home visits to screen for referrals and services based on their 
identified needs from the initial risk assessment that is to be completed upon entry into the 
program. The initial risk assessment is a comprehensive risk screening tool that was developed 
and modified for over 12 years by LCHS. It is administered by the CN to the client and is used to 
assess the participant’s health and well-being, based elements such as income, family size, 
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demographic characteristics, previous pregnancy outcomes, stress, social and behavioral factors 
(e.g. smoking, alcohol or drug use), personal and family medical history, physiological data, and 
medical and psychosocial risk factors and conditions (e.g. diabetes, hypertension, depression, 
family conflict, domestic violence). Through the risk screening, the CN refers the client to the 
appropriate appointments and educational services, and they work closely with each client to 
track these services, both prenatal and postpartum.  
LCHS activities related to interconceptional care (ICC) and family planning (FP) include  
 home visits that incorporate a strong educational curriculum for ICC and FP; 
 collaborations with other local health systems to facilitate collective impact on 
women’s access to a consistent and seamless service delivery and support system; 
 case management services for each client to effectively navigate the system; 
 follow-up support to help clients establish a medical home as a permanent 
connection to the health care system; 
 follow-up support to ensure a that a client leaves the hospital post-delivery with a 
contraceptive method in hand; and 
 follow-up support to ensure that women are effectively using a contraceptive 
method at periodic intervals over the 24-month postpartum enrollment. 
LCHS personnel and the obstetricians and nurse midwives at the hospital form a 
collective effort to increase the number of clients who leave the hospital with a Depo Provera 
injection after delivery. CNs coach prenatal women to ask for the injection. Some methods to 
ensure that women receive follow-up of some form is by scheduling immunization or Well-Child 
appointments, to which clients are obliged to bring their children for required visits and are able 
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to receive a check-up themselves. The program protocol compensates the client with cash for 
each appointment, since client retention becomes more difficult during postpartum. LCHS tracks 
all appointments and assessments in a web-based database system that is managed by the South 
Carolina Budget and Control Board, Division of Research and Statistics-Health Demographics. 
3.3 Measures 
3.3.1 Outcome measure. The outcome measure of interest for both Aim 1 and Aim 2 
was time, in months, to RRP, given the clients who experienced the outcome as well as the 
clients who, in her length of recorded enrollment in LCHS, did not experience a short IPI (≤ 24 
months). LCHS enters information for each time that a client delivers an infant while enrolled in 
the program. If a client enters the program during her postpartum period, the study used her 
index delivery date based on her self-report. When a client confirms a subsequent pregnancy, this 
new pregnancy start date is estimated from her latest reported menstrual cycle. The IPI was 
measured, in months, from the delivery date of the index child to the estimated start date of the 
subsequent pregnancy. 
3.3.2 Explanatory variables. 
Postpartum contraceptive decisions. It is important to emphasize that the contraceptive 
methods adjusted for in these two analyses represent the client’s choice, adherence and 
consistency to the contraceptive methods. Biologically, the contraceptive methods, if used 
correctly, do protect against pregnancy, with the exception of condom breakage. For Aim 1, the 
Depo injection is measured at discharge from the hospital after the client’s index delivery, so that 
a client either received a Depo injection at discharge (1) or did not receive a Depo injection at 
discharge (0). For Aim 2, the Depo injection is measured at each issuance of the injection, as are 
the other contraceptive methods that LCHS offers to its clients. The CN that works with the 
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client tracks each date that each method of contraception is given to the client and records the 
expiration date of the contraceptive method and, thus, the next required follow-up visit date. 
Based on past literature and the purposes of the research question, the other contraceptive 
methods were categorized into maintenance (OCP, patch, ring), barrier (vaginal spermicide, 
condom, film), and LARC (Implanon, Norplant, Mirena, IUD). For the Aim 2 analysis, each 
category of contraceptive method was coded as a time-varying dichotomous value, in which the 
method is considered to be in use (1) starting from its issue date and ending on its expiration 
date. The method is considered in nonuse (0) starting from the expiration date and ending on the 
next date that the client receives the same method. 
Demographic risk factors. LCHS records each client’s date of birth as well as her date of 
entry into the program. The study used the client’s age at entry (number of years between entry 
date and client’s date of birth) into LCHS as a proximate measure of her age at the conception of 
her index baby, treated as a continuous variable. Of the available socioeconomic characteristics 
that LCHS records for each client during the initial risk assessment, educational status was 
reported the most by clients, and was thus chosen for a potential explanatory variable. The study 
treated limited education as a dichotomous variable, indicating whether the client did not finish 
high school before she became pregnant (1) or she did finish high school (0). 
Psychosocial risk factors. The study considered prenatal and postpartum depression for 
potential inclusion into the models. Upon entry into LCHS, each client completes the Edinburg 
Depression Screening (EPDS) questions to detect any risk for prenatal depression, if they entered 
the program while pregnant, or for postpartum depression, if they entered the program after 
giving birth. Clients who were screened for prenatal depression were screened again four weeks 
postpartum for risk of postpartum depression. The EPDS consists of ten short statements and a 
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four-level Likert scale in response to each statement. For LCHS purposes, an EPDS score of 12 
or greater indicates a high risk of depression. The study treated both prenatal and postpartum 
depression scores as continuous variables. 
 The study took into account whether or not a client’s index birth resulted in a live birth or 
a fetal death (birth outcome). If the client enters the program after her index delivery, she is 
asked during the initial risk assessment to list her past pregnancies and the birth outcome of each. 
If she enters the program while pregnant, the CN reports the details of the delivery, including 
birth outcome, into the database. In the initial risk assessment, for deliveries that occurred prior 
to entry into LCHS, LCHS categorizes birth outcomes as a live birth, a fetal death, or an infant 
death before his or her first birthday. For deliveries that occurred while the client was enrolled in 
LCHS, LCHS categorizes birth outcomes as a live birth, a spontaneous abortion (miscarriage or 
loss of fetus <28 weeks), an elected abortion, or a fetal death (fetus >28 weeks of gestation). For 
this study, birth outcome was treated as a dichotomous variable for either a live birth (1) or a 
fetal death (0), in which any outcome that was not reported as a live birth was categorized as a 
fetal death. For each pregnancy that the client reports happening prior to entry into LCHS, as 
well as for each pregnancy that she experiences while in LCHS, the CN records whether or not 
the pregnancy was unplanned. The study treated the intention of the index pregnancy as a 
dichotomous variable, either unplanned (1) or planned (0). 
 Other factors that were tested for potential inclusion into the models, specifically 
important aspects of the client’s relationship health, were whether or not (1) the father of the 
index baby is involved, (2) a male is emotionally involved, (3) the client’s partner drinks, (4) the 
client experienced emotional abuse, and (5) the client experienced physical abuse during her 
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index pregnancy. These characteristics are self-reported by the client in her initial risk 
assessment. The study treated each of these variables as dichotomous on a yes (1) or no (0) basis. 
Behavioral risk factors. LCHS reports pregnancy-related behaviors, including a client’s 
plan to breastfeed, the trimester that she started prenatal care, and the trimester that she entered 
LCHS, for each delivery that she experiences while enrolled. The study took into account a 
client’s decision to breastfeed (1) or not (0) after her index delivery. For the trimester that the 
client began prenatal care and for the trimester that she entered LCHS, the CN records either first 
trimester, second trimester, third trimester, or not applicable/postpartum for each. For the study, 
the two variables were treated as dichotomous, so that the client either received prenatal care 
during her first, second, or third trimester (1) or did not receive prenatal care (0), and that she 
either enrolled in LCHS while in her first, second, or third trimester (1) or postpartum (0). 
The remaining available behavioral risk factors that the study considered are measured 
during the initial risk assessment by the client’s self-report as yes (1) or no (0). The study 
included whether a client was physically active (1) or not (0) as a potential explanatory variable. 
Although the literature lacks much information on the relationship between physical activity and 
IPI, there may exist some linkage between the behavioral and biological aspects of physical 
activity and whether or not a woman experiences a RRP. The study also took into account clients 
who reported having sex without a condom (1) versus clients who reported that they did not have 
sex without a condom (0).  Finally, the study also considered whether the client reported having 
multiple sex partners (1) or did not have multiple sex partners (0). 
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3.4 Analysis 
3.4.1 Overview. The study used descriptive statistics to describe the study population, 
excluded clients, and final sample. We used t-tests and chi-square tests of association, where 
appropriate, to compare the final sample with the excluded clients. We used Kaplan Meier 
survival curves to observe time to RRP for each covariate in the final sample as well as between 
the study sample and the final sample used for analysis. Age at entry and prenatal depression 
score were stratified on their means for the Kaplan-Meier survival curves. We performed two 
analyses, one using a model to fit significant covariates for Aim 1 (Model 1) and one using a 
separate model with the same baseline covariates for Aim 2 (Model 2). Unadjusted and adjusted 
hazard ratios were calculated for both models. Data merging and preparation, hazard ratios, 
confidence intervals for the hazard ratios, and p-values were all obtained using Statistical 
Analysis System (SAS) version 9.4. 
3.4.2 Model building and diagnostics. First, for Aim 1 model building, all potential 
explanatory variables were tested separately for association with IPI using Kaplan-Meier 
survival curves and the log-rank test, with a more conservative α of 0.1 in order to avoid 
excluding predictors that may have been significant after adjusting for other covariates. 
Covariates that were statistically significant were included in the initial choices for Model 1. The 
exceptions were age and Depo injection at discharge, which were included in the model 
regardless of statistical significance. Variables in Model 1 that were no longer significant after 
adjusting for other covariates were removed using a backward elimination, unless the partial log 
likelihood test for the model with and without a particular covariate resulted in a significant 
difference, in which case the variable remained in the model. Variables whose log-rank test 
statistics were not significant were inserted separately into the adjusted Cox model to test for 
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statistical significance (α = 0.05), adjusting for other variables. Martingale residuals with a 
lowess smoothed plot were used to test for a linear relationship between the continuous variables 
(age and prenatal depression score) against the outcome (time to RRP). Once the appropriate 
main effects and transformations were obtained for the model, each explanatory variable was 
tested for interaction with each other explanatory variable (α = 0.05). Deviance residuals were 
used to detect the percentage and extent of poorly predicted outcomes. Schoenfeld residuals fit to 
a lowess smoothed plot and rank-transformed time were used to test the proportional hazards 
assumption for each explanatory variable. Any explanatory variable that did not meet the 
proportional hazards assumption was tested for interaction with time. The difference in sample 
log cumulative hazard functions for the covariate over time was used to choose the function of 
time interaction. Finally, score residuals were used to detect influential cases. The same main 
effects that were fitted to the adjusted model in Aim 1 for statistical significance were also fitted 
to the adjusted model for Aim 2, which took into account the time-varying use of contraceptive 
methods, specifically Depo injections over time, maintenance methods, barrier methods, and 
LARC methods. The same procedures for testing for interactions, linearity, and proportional 
hazards were used for the Aim 2 model building.  
Postpartum Contraception and Rapid Repeat Pregnancies29 
 
3.4.3 Censored data. The analysis took into account right censoring of the data, in which 
a client did not have a record within LCHS of experiencing a subsequent pregnancy. For the 
purpose of this study, IPIs were observed only if the client experienced one within 24 months of 
her index birth into LCHS. Thus, the analysis includes both clients who were censored prior to 
the 24-month cutoff point as well as clients who were censored at 24 months. 37 (1.75%) of the 
2,115 clients who were not observed to have a RRP were censored at 24 months, while the other 
2,078 were censored prior to 24 months. 
3.4.4 Missing data and exclusion criteria. For the analysis, SAS was not able to include 
any records with missing covariates in the Cox model. Thus, all clients with any missing 
explanatory variable were excluded from the final sample. Clients with only a single record in 
the data set were excluded, as well. T-tests and chi-square tests of association were used to 
compare continuous and dichotomous covariates, respectively, between the excluded clients and 
the final sample. Because of missing data for the explanatory variables, the final sample size 
could only be known after the appropriate explanatory variables were determined for the 
adjusted model. 
Results 
5.1 Descriptive Statistics 
Out of the 2,260 clients eligible to be included in the study, 761 were included in the 
analysis with the above exclusion criteria. Table 1 includes descriptive statistics for relevant 
demographic variables for the overall study population, those excluded from the analysis, and 
those included in the analysis of the Cox model. The final sample reflects the demographic 
characteristics of the Low Country region, specifically a predominantly African American 
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(96.98%), non-Hispanic (99.64%) population. The tests of differences between the included and 
excluded samples showed which variables are not missing completely at random for the study 
population. Overall, the included sample consisted of a much greater proportion of IPIs shorter 
than 24 months, c2(1, N = 2,260) = 102.6, p < 0.001, although it had a mean IPI about two 
months longer than the excluded sample, t(927.53) = 10.36, p < 0.001. The majority of clients 
were younger than 23, and the final sample was younger by a statistically significant yet small 
difference in magnitude, t(1648.6) = 4.23, p < 0.001.  
Table 2 contains similar statistics and comparisons for the pregnancy-related variables. A 
much greater proportion of those included in the study received the Depo injection at discharge, 
c2(1, N = 2,260) = 85.86, p < 0.001, and a much greater proportion of those included in the study 
ever received a Depo injection over time, c2(1, N = 2260) = 141.9, p < 0.001. For all 
contraceptive method categories, a significantly greater proportion of clients who were included 
in the analysis had ever received a contraceptive method of that type. Also, the average length of 
time that a client was prescribed a contraceptive method was significantly greater for those 
included in the analysis than those who were excluded, except for the barrier method, in which 
the difference in proportion was not significant. In the included sample, 3.89% more clients 
planned to breastfeed than the excluded sample, c2(1, n = 1,840) = 5.27, p = 0.022. A 
significantly smaller proportion of clients included in the final sample reported having sex 
without a condom, c2(1, N = 1808) = 7.55, p = 0.006, as was the case for being emotionally 
involved with a male, c2(1, N = 1,957) = 11.48, p < 0.001.   
Postpartum Contraception and Rapid Repeat Pregnancies31 
 
Table 1: Descriptive Statistics for Demographic Variables 
Characteristics (% missing) Study 
population 
(n=2,260) 
Excluded 
(n=1499) 
Final 
sample 
(n=761) 
P 
Experienced a short IPI 140 6.19 38 2.54 102 13.40 <0.001 
Time to RRP*, M (SD) 10.11 (5.89) 8.60 (5.30) 10.68 (6.02) <0.001 
Age at entry into LCHS (0.53), M (SD) 21.90 (5.07) 22.23 (5.19) 21.27 (4.78) <0.001 
12-17 422 18.8 254 17.08 168 22.08 − 
18-23 1136 50.5 734 49.36 402 52.83 − 
24-29 476 21.2 342 23.00 134 17.61 − 
30-35 177 7.9 130 8.74 47 6.18 − 
36-42 37 1.7 27 1.82 10 1.31 − 
Race (0.27)       0.034 
Black or African American 2145 95.16 1407 94.24 738 96.98 − 
Caucasian 94 4.17 71 4.76 23 3.02 − 
Asian 6 0.27 6 0.13 − − − 
American Indian or Alaska Native 2 0.09 2 0.13 − − − 
Native Hawaiian or other Pacific 2 0.09 2 0.13 − − − 
Unknown/Other 5 0.22 5 0.33 − − − 
Ethnicity (20.97)       0.001 
Not Hispanic or Latino 1746 97.76 1200 96.93 546 99.64 − 
Hispanic or Latino 19 1.06 17 1.37 2 0.36 − 
Unknown 21 1.18 21 1.70 − − − 
Limited education, less than high school 
(29.73) 
819 51.57 497 53.56 322 48.79 0.061 
Note. n % unless otherwise noted. 
* Kaplan-Meier test of time to RRP (results of log-rank test) 
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Table 2: Descriptive Statistics for Pregnancy-Related Variables 
Characteristic (% missing) Study 
Population 
(n=2,260) 
Excluded 
(n=1,499) 
Final 
sample 
(n=761) 
P 
Received Depo injection at discharge 
(0) 
655 28.98 340 22.68 315 41.39 <0.001 
Ever received a Depo injection 936 41.42 489 32.62 447 58.74 <0.001 
Total length of Depo use, M (SD) 2.83 (4.85) 2.06 (4.24) 4.35 (5.57) <0.001 
Ever received a maintenance method 
of contraception (0) 
486 21.50 248 16.54 238 31.27 <0.001 
Total length of maintenance use, M 
(SD) 
 
1.11 (3.15) 0.77 (2.57) 1.80 (3.97) <0.001 
Ever received a barrier method of 
contraception (0) 
187 8.27 96 6.40 91 11.96 <0.001 
Total length of barrier use, M (SD) 0.26 (1.29) 0.23 (1.25) 0.31 (1.35) 0.159 
Ever received a LARC (0) 343 15.18 182 12.14 161 21.16 <0.001 
Total length of LARC use, M (SD) 0.34 (1.95) 0.27 (1.77) 0.46 (2.25) 0.049 
Trimester began prenatal care (20.04)       0.537 
First trimester 1,438 79.58 812 77.41 626 82.59 − 
Second trimester 282 15.61 184 17.54 98 12.93 − 
Third trimester 62 3.43 40 3.81 22 2.90 − 
No prenatal care 24 1.33 13 1.24 12 1.58 − 
Trimester began LCHS (18.54)       0.950 
First trimester 758 41.17 407 37.69 351 46.12 − 
Second trimester 674 36.61 401 37.13 273 35.87 − 
Third trimester 382 20.75 256 23.70 126 16.56 − 
Postpartum 27 1.47 16 1.48 11 1.45 − 
Plan to breastfeed (18.58) 279 15.16 181 16.77 98 12.88 0.022 
Index birth outcome (18.81)       0.011 
Live birth 1,773 96.62 1,028 95.72 745 97.90 − 
Spontaneous abortion 44 2.40 36 3.35 8 1.05 − 
Fetal death 13 0.71 6 0.56 7 0.92 − 
Still birth 4 0.22 3 0.28 1 0.13 − 
Elected abortion 1 0.05 1 0.09 − − − 
Postpartum depression risk, EDS ≥ 12 
(59.03) 
33 3.56 3 1.82 30 3.94 − 
M (SD) 1.62 (3.63) .903 (2.80) 1.77 (3.77) 0.001 
Father is involved (7.57) 1,697 81.24 1,099 82.14 598 79.63 0.159 
Emotionally involved with a male 
(13.41) 
1,631 83.34 1,062 85.51 569 79.58 0.001 
Emotionally abused (4.91) 165 7.68 107 7.70 58 7.63 0.952 
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Characteristic (% missing) Study 
Population 
(n=2,260) 
Excluded 
(n=1,499) 
Final 
sample 
(n=761) 
P 
Physically abused during pregnancy 
(4.73) 
57 2.65 38 2.73 19 2.50 0.747 
Partner drinks (4.82) 752 34.96 494 35.54 258 33.90 0.447 
Unplanned index pregnancy (29.60) 1,342 84.35 694 83.61 648 85.15 0.399 
Multiple sex partners (39.51) 180 13.17 111 14.68 69 11.29 0.065 
Has sex without a condom (20.00) 1,195 66.10 756 68.54 439 62.27 0.006 
Physically active (40.93) 39 2.92 20 2.73 19 3.15 0.651 
Note. n % unless otherwise noted. 
 
5.2 Model Building and Diagnostics 
Table 3 shows the results of the Kaplan-Meier survival estimate log-rank tests for each 
potential explanatory variable. The variables that were significantly associated (α = 0.1) with 
time to RRP by the nonparametric test of the survival function were first entered into the 
adjusted Cox model. Figure 1 illustrates the Kaplan-Meier survival curves for those who 
received the Depo injection at discharge and for those who did not receive the Depo injection at 
discharge, in the final sample. Epanechnikov kernel-smoothed hazard functions corresponding to 
the Depo injection at discharge are given in Figure 2, and they indicate that the hazard rates do 
not change proportionally over time. The diagnostics for this occurrence will be discussed further 
below. After entering the covariates into the Cox model, variables were deleted for statistically 
insignificant association, either by the Wald chi-square test or by the partial log-likelihood test, 
in the following order: prenatal care, prenatal entry into LCHS, prenatal depression score, father 
involvement, birth outcome, plan to breastfeed, sex without a condom, and physical activity. 
Plan to breastfeed initially contributed to a significant change in partial log-likelihood when 
included in the model, but it was no longer a significant variable after removing sex without a 
condom and physical activity.   
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Table 3: Difference in K-M Estimated Survival Rates for the Study Population 
Variable (n = 2,260) P 
Received Depo injection at discharge 0.124 
Limited education 0.661 
Received prenatal care <0.001 
Prenatal entry into LCHS <0.001 
Planned to breastfeed 0.095 
Index birth resulted in a live birth 0.019 
Had sex without a condom 0.058 
Had multiple sex partners 0.394 
Partner drank 0.301 
Unplanned index pregnancy 0.004 
Physically active 0.008 
Experienced physical abuse during pregnancy 0.034 
Father of the baby is involved 0.048 
Age at entry into LCHS* 0.226 
Prenatal depression score* 0.014 
Postpartum depression score* <0.001 
*Stratified on the mean 
 
 
Figure 1: Kaplan-Meier Survival Curves for Depo Injection at Discharge, Final Sample 
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Figure 2: Hazard Function for Depo at Discharge, Unadjusted, Final Sample 
Figure 3 shows the lowess smoothed line fit to the martingale residuals for postpartum 
depression score and age. In the right-hand panel, age shows a relatively linear trend over time, 
indicating that a linear prediction of age is appropriate for the model. In contrast, the left panel 
shows a lowess smoothed line with a nonlinear trend over time for postpartum depression score, 
indicating that a transformation is needed for that variable. A square root transformation for 
postpartum depression score gave it a linear trend over time in relation to time to RRP, therefore 
satisfying the linearity assumption for the Cox model. 
No covariate interaction was found for during the model building for Aim 1. Depo 
injection at discharge did not meet the proportional hazards assumption, according to the 
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Schoenfeld residuals (Figure 4, left panel), and the variable showed a significant interaction (r = 
0.22, c2 = 4.99, p = 0.026) with time with a lowess smoothed line that showed systematic 
deviation from the line at β(t) = 0 with a slope of 0 over the ranked time. In contrast, unplanned 
index pregnancy (Figure 4, right panel), resulted in a lowess smoothed line that had a relatively 
linear slope approximately equal to 0, indicating that it did not demonstrate evidence of non-
proportionality, r = -0.07, c2 = 0.51, p = 0.477. The difference between the sample log 
cumulative hazard functions between those who did not receive the Depo injection at discharge 
and those who did declined steeply over time, indicating that a log function of time was 
appropriate in modeling the time-varying effect of Depo injection at discharge (Figure 5). The 
final model included Depo injection at discharge as well as its interaction with the log function 
of time, unplanned index pregnancy, physical abuse during pregnancy, postpartum depression 
score, and age. Figure 6 shows the cumulative hazard plot for Depo injection at discharge, not 
adjusting for its time-varying effects.  
Table 4 displays the regression model parameter estimate, standard error, hazard ratio, 
and 95% confidence interval for each variable term. The column labeled “Unadjusted” contains 
such information for each variable as a separate model. The middle column, labeled “Adjusted” 
contains HRs that are comparable to those of the unadjusted models for each variable. The right-
hand column, labeled “Adjusted with Interaction,” contains the model that adjusts for the time-
varying effects of Depo injection at discharge, as necessary due to the variable’s non-
proportional hazard function. 
 
 
  
Figure 3: Martingale Residuals for Postpartum Depression Score (left) and Age (right) 
 
  
Figure 4: Schoenfeld Residuals for Depo Injection at Discharge (left) and Unplanned Index Pregnancy (right) 
 
 
 
Figure 5: Difference in Sample Log Cumulative Hazard Functions, Final Sample 
 
Figure 6: Cumulative Hazard Plot for Depo injection at discharge in Aim 1 
 
 
Unplanned index pregnancy, physical abuse during pregnancy, postpartum depression 
score, and age were similarly included, along with the time-varying contraceptive method 
variables, in the model building for Aim 2. In the adjusted model, receiving Depo injections over 
time satisfied the proportional hazards assumption, r = -0.03, c2 = 0.12, p = 0.74. As seen in 
Figure 7, receiving Depo injections over time provided a strong protective factor against RRP, as 
expected. A significant interaction existed between physical abuse during pregnancy and 
postpartum depression score in the adjusted model for Aim 2. LARC did not meet the 
proportional hazards assumption, r = 0.24, c2 = 6.37, p = 0.012, and the variable showed a 
significant interaction with time. Finally, a significant interaction existed between physical abuse 
during pregnancy and postpartum depression score. Table 5 displays the results of the model 
building for Aim 2 in the same manner as Table 4 does for the model building for Aim 1.  
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Figure 7: Cumulative Hazard Plot for Depo Injections over Time in Aim 2 
 
 
Table 4: Cox Proportional Hazards Model Fitting for Aim 1 
Variable Unadjusted* Adjusted Adjusted with interaction 
 β SE P HR 95% CI β SE P HR 95% CI β SE P HR 95% CI 
Received Depo 
injection at 
discharge 
-0.61 0.22 0.004 0.54 0.36-0.83 -0.66 0.22 0.003 0.52 0.34-0.80 3.39 0.81 <.001 29.63 6.05-145.14 
Index pregnancy 
was unplanned 
-0.66 0.23 0.004 0.52 0.33-0.81 -0.64 0.23 0.005 0.53 0.34-0.83 -0.61 0.23 0.007 0.54 0.35-0.85 
Physical abuse 
during 
pregnancy 
0.82 0.46 0.073 2.28 0.93-5.60 0.93 0.47 0.047 2.54 1.01-6.36 0.84 0.47 0.071 2.32 0.93-5.77 
Postpartum 
depression score 
0.30 0.07 <.001 1.34 1.18-1.53 0.27 0.07 <.001 1.31 1.14-1.50 0.29 0.07 <.001 1.33 1.16-1.53 
Age at entry -0.03 0.02 0.134 0.97 0.93-1.01 -0.04 0.02 0.078 0.96 0.92-1.00 -0.03 0.02 0.135 0.97 0.93-1.01 
Received Depo 
injection at 
discharge × 
log(Time) 
− − − − − − − − − − -1.53 0.31 <.001 0.22 0.12-0.40 
* Unadjusted results are for separate Cox proportional hazard models including each covariate as a single predictor. 
 
 
Table 5: Cox Proportional Hazards Model Fitting for Aim 2 
Variable Unadjusted* Adjusted Adjusted with interaction 
 β SE P HR 95% CI β SE P HR 95% CI β SE P HR 95% CI 
Received Depo 
injections over time 
-1.80 0.33 <.001 0.17 0.09-0.32 -1.83 0.34 <.001 0.16 0.08-0.31 -1.82 0.34 <.001 0.16 0.08-0.32 
Maintenance (OCP, 
ring, patch) 
0.01 0.24 0.970 1.01 0.63-1.63 -0.48 0.25 0.058 0.62 0.38-1.02 -0.47 0.25 0.066 0.63 0.38-1.03 
Barrier (vaginal 
spermicide, condom, 
film) 
1.21 0.30 <.001 3.37 1.88-6.03 0.58 0.31 0.061 1.80 0.97-3.31 0.60 0.31 0.056 1.82 0.99-3.36 
LARC (Implanon, 
Norplant, Mirena, 
IUD) 
0.05 0.46 0.906 1.06 0.43-2.59 0.12 0.47 0.795 1.13 0.45-2.85 -3.05 1.82 0.093 0.05 0.001-1.66 
Index pregnancy was 
unplanned 
-0.73 0.21 0.001 0.48 0.32-0.73 -0.63 0.22 0.004 0.53 0.35-0.82 -0.62 0.22 0.005 0.54 0.35-0.82 
Physical abuse during 
pregnancy 
0.74 0.46 0.105 2.10 0.86-5.15 1.62 0.56 0.004 − − 1.62 0.56 0.004 − − 
Postpartum 
depression score 
0.33 0.06 <.001 1.39 1.23-1.57 0.28 0.07 <.001 − − 0.28 0.07 <.001 − − 
Physical abuse during 
pregnancy × 
Postpartum 
depression score 
− − − − − -0.84 0.39 0.032 − − -0.83 0.39 0.035 − − 
Age at entry -0.04 0.02 0.097 0.97 0.93-1.01 -0.05 0.02 0.020 0.95 0.91-0.99 -0.05 0.02 0.024 0.95 0.91-0.99 
LARC × Time − − − − − − − − − − 0.23 0.10 0.029 1.25 1.02-1.53 
* Unadjusted results are for separate Cox proportional hazard models including each covariate as a single predictor. 
 
 
5.3 Model Interpretation 
 For Aim 1 (Table 4), a client who received the Depo injection at discharge had a 
RRP rate about 46% slower than that of a client who did not receive the Depo injection at 
discharge (unadjusted HR = 0.54, 95% CI: 0.36- 0.83; adjusted HR = 0.52, 95% CI: 0.34-0.8). 
However, after adjusting for the time-varying effect of Depo injection at discharge, receiving the 
Depo injection at discharge resulted in a much later RRP than not receiving the Depo injection at 
discharge (HR = 29.63, β = 3.39, 95% CI: 6.049-145.141). Over time, the HR for receiving the 
Depo injection at discharge decreased gradually (HR = 0.22, β = -1.53, 95% CI: 0.12-0.40), so 
that, by about 9.15 months1 postpartum, receiving the Depo injection at discharge became a more 
protective factor against RRP than not receiving the Depo injection at discharge. 
In order to estimate survival rates, it was necessary to disregard the time-varying effects 
of receiving the Depo injection at discharge. The survival estimates for each explanatory variable 
in Aim 1, not accounting for any time-varying effect, is given in Table 6. The survival rates for 
Depo injection at discharge were overestimated at 6 and 12 months, since earlier postpartum was 
associated with a higher hazard ratio for those who received the Depo injection at discharge. 
Comparing the survival estimates for each explanatory variable, adjusted for other covariates at 
their reference category (0) or mean values, to the reference set of covariates (“Reference 
baseline,” Table 6), revealed approximate differences that those covariates produced on time to 
RRP. Physical abuse during pregnancy had a deleterious effect on rapid repeat pregnancy, 
although the confidence interval reaches 100% survival rate over each period of time. The 
survival rates for the postpartum depression score were calculated at the mean (EDS = 0) and at 
the 90% quantile (EDS = 6). The higher the postpartum depression score, the lower the survival 
                                                          
1 3.39 − 1.53 × ln(9.15) ≈ 0, indicating the point in time that the parameter for the variable becomes negative. 
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rate over time. The older the client’s age at pregnancy with her index child, the greater the 
survival rate over time. 
Table 5 shows that, for Aim 2, receiving Depo injections over time resulted in a much 
lower hazard rate than not receiving Depo injections over time (unadjusted HR = 0.17, 95% CI: 
0.09-0.32; adjusted HR = 0.16, 95% CI: 0.08-0.31). Due to the differing results between the 
time-varying effects of Depo injection at discharge and whether or not a client received the 
injection over time, we tested the addition of receiving Depo injection at discharge to the 
adjusted model for Aim 2 for association and interaction with other contraceptive methods. 
Adjusting for all other variables in the second model, including receiving Depo injections over 
time, receiving the Depo injection at discharge resulted in a lower hazard rate than not receiving 
the Depo injection at discharge, although the association was not significant (adjusted HR = 0.88, 
p = 0.544, 95% CI: 0.57-1.34). There was no significant interaction between receiving the Depo 
injection at discharge and receiving Depo injections over time. Similarly, there was no 
significant interaction between receiving the Depo injection at discharge and any other 
contraceptive method variable. Clients who received the other methods of contraception did not 
show statistically significant effects on time to RRP at α = 0.05. LARC showed a highly 
protective but not statistically significant effect against RRP (adjusted HR = 0.05, p = 0.093, 
95% CI: 0.002-2.26), but that protective effect decreased multiplicatively by about .25 with each 
passing month (HR = 1.25, p = 0.029, 95% CI: 1.02-1.53).
 
 
Table 6: Survival Rates over Time for Aim 1 Adjusted Model 
Variable 6 Months 12 Months 18 Months 
% 95% CI % 95% CI % 95% CI 
Reference baseline a 89.1 84.0-94.4 74.4 65.4-84.7 59.4 47.7-73.9 
Depo injection at 
discharge 
94.2 91.0-97.5 85.8 79.3-92.9 76.3 66.7-87.4 
Unplanned index 
pregnancy 
94.1 91.8-96.4 85.0 81.5-89.9 76.0 70.2-82.4 
Physical abuse during 
pregnancy 
74.5 54.6-100 47.3 21.9-100 26.6 6.96-100 
Postpartum 
depression score 
0 92.2 88.2-96.3 81.3 73.6-89.8 69.4 58.6-82.2 
6 b 85.5 78.8-92.8 67.2 56.0-80.6 49.5 36.3-67.6 
Age at entry c 14 85.6 78.2-93.8 67.4 54.5-83.3 49.8 34.5-71.9 
18 87.6 81.8-93.8 71.4 61.2-83.3 55.2 42.5-71.8 
25 90.5 85.8-95.5 77.5 68.8-87.4 63.8 52.1-78.2 
30 92.1 87.4-97.1 81.2 71.8-91.9 69.2 56.1-85.5 
a All dichotomous variables set to 0, all continuous variables set to their mean 
(postpartum depression score = 1.77, age = 21.9). 
b 90% quantile of the final sample 
c Values chosen arbitrarily 
 
When adjusting for all explanatory variables including the LARC interaction with time, 
the HR for physical abuse during pregnancy decreased as the postpartum depression score 
increased (At EDS = 0: HR = 5.05, 95% CI: 1.69-15.2; at EDS = 6: HR = 1.68, 95% CI: 0.62-
4.55; at EDS = 6: HR = 0.67, 95% CI: 0.14-3.16). The 95% confidence intervals indicate that, at 
lower EDS scores for postpartum depression, physical abuse during pregnancy had a significant 
effect on time to RRP, but, at higher EDS scores, the effect of physical abuse during pregnancy 
was no longer statistically significant. Figure 8 displays the interaction effect between physical 
abuse during pregnancy and postpartum depression score on the cumulative hazard rates of time 
to RRP. The top left panel shows that, with no risk of postpartum depression, physical abuse 
during pregnancy results in a much higher hazard rate over time than no physical abuse during 
pregnancy. This difference decreases at the mean postpartum depression score for this sample 
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(1.77), although the mean postpartum depression score indicates little risk of postpartum 
depression. The bottom panel shows the cumulative hazard plot for clients in the 90% quantile of 
postpartum depression scores (EDS = 6). For the clients experiencing that level of postpartum 
depression, those who were physically abused actually had a lower hazard rate for time to RRP 
than those who were not physically abused. For the purpose of estimating survival rates, the 
adjusted model was fitted without a time-varying effect of LARC, so that receiving LARC had a 
statistically insignificant adjusted HR of 1.13 (β = 0.12, p = 0.795, 95% CI: 0.45-2.85). Survival 
rates for the adjusted model for Aim 2, without the time-varying effect of LARC, are given in 
Table 7. For physical abuse during pregnancy, the survival rates displayed are at each level of 
postpartum depression that the client scored (0 and 6).
 
 
  
 
Figure 8: Cumulative Hazard Plots for Physical Abuse during Pregnancy at Various Postpartum Depression Scores
 
 
Table 7: Survival Rates over Time for Aim 2 Adjusted Model 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Discussion and Conclusion 
6.1 Depo Injection at Discharge and Depo Injections over Time 
When receiving Depo injections over time, 90.2% (98% CI: 83.8-97.0) of clients had not 
conceived again at 18 months. For Aim 2, the most protective factor was continuing the Depo 
injections over time. Disregarding the time-varying effects of receiving a Depo injection at 
discharge, about 76.3% (95% CI: 66.7-87.4) of clients who received the Depo injection at 
discharge had not conceived again by 18 months. For Aim 1, adjusting for the time-varying 
effect of Depo injection at discharge indicated that the Depo injection at discharge had an 
increasingly protective effect across time. This does not reflect a time-varying effect of Depo at 
Variable 6 Months 12 Months 18 Months 
% 95% CI % 95% CI % 95% CI 
Reference baseline a 86.5 80.5-93.0 69.1 59.0-81.0 52.4 40.2-68.4 
Depo injections over 
time 
97.7 96.0-99.4 94.3 90.4-98.3 90.2 83.8-97.0 
Maintenance method 91.4 86.5-96.7 79.6 70.0-90.4 67.1 54.0-83.4 
Barrier method 77.1 64.7-92.1 51.5 34.0-78.0 31.4 15.5-63.7 
LARC method 84.9 71.8-100 65.8 43.5-99.7 48.2 23.5-98.9 
Unplanned index 
pregnancy 
92.6 89.7-95.5 82.1 77.1-87.4 70.8 70.2-82.4 
Physical abuse during 
pregnancy b 
      
Postpartum 
depression 
score 
0 60.5 33.6-100 27.7 6.3-100 10.6 0.8-100 
6 c 82.0 74.1-90.6 60.1 48.1-75.3 41.2 28.2-60.1 
Age at entry d 14 80.8 71.4-91.4 58.0 43.7-77.1 38.6 23.7-62.9 
18 84.2 77.1-91.9 64.4 53.0-78.3 46.4 33.3-64.5 
25 88.8 83.4-94.6 73.9 64.0-85.2 58.9 46.4-74.8 
30 91.3 86.1-96.9 79.3 69.0-91.1 66.7 52.6-84.4 
a All dichotomous variables set to 0, all continuous variables set to their mean 
(postpartum depression score = 1.77, age = 21.9). 
b Measured at the given levels of postpartum depression score 
c 90% quantile in the final sample 
d Values chosen arbitrarily 
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discharge itself, which is biologically effective for three months. Instead, it may suggest a 
relationship between receiving the Depo injection at discharge and the continued use of the Depo 
injection or other highly effective contraceptive methods over time, which is the focus of the 
Aim 2 analysis. The drastically large HR at time zero occurs from the logarithmic transformation 
of time for the interaction. The large HR in the earlier months, therefore, may reflect the client’s 
behavior with contraception soon after she received the Depo injection at discharge. The time-
varying effect suggests that, for the first nine months, a client who received the Depo injection at 
discharge may not have kept immediate and consistent use of a contraceptive method after her 
Depo injection expired, hence experiencing a RRP. On the other hand, clients who retained a 
contraceptive method beyond nine months after receiving the Depo injection at discharge likely 
experienced a longer IPI or no RRP at all. Aim 2 showed that sustained use of the Depo injection 
is protective against RRP. Fitting Depo injection at discharge into Model 2 showed that it may 
not affect overall Depo use, but that it may matter indirectly, signifying that continued use of 
contraception method is an important outcome for future research. The hypothesis that receiving 
the Depo injection at discharge provides a protective factor against short IPIs holds true, but the 
results suggest underlying behavioral factors in clients who experience an IPI of less than nine 
months for which the hypothesis is rejected. The second hypothesis that receiving the Depo 
injection over time holds true, as would be expected for a client who consistently adheres to the 
proper usage. 
6.2 Long-Acting Reversible Contraceptives 
 In the Aim 2 analysis, LARC had the largest effect, although it was not statistically 
significant. The time-varying effect of LARC becomes less and less negative, likely reflecting 
that as long as the client is on a LARC, they are protected. Biologically, being on a LARC 
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renders the chance of conception to be essentially zero, unless the LARC is removed and 
discontinued. Thus, the increasing hazard ratio over time must reflect the client’s use of the 
LARC. The standard error for the effect of LARC is large, which is likely due to the low rate of 
use in the sample and the resulting sampling error.  
6.3 Maintenance and Barrier Contraceptive Methods 
Maintenance methods of contraception, such as the OCP, the ring, and the patch, have a 
small and marginally significant protective factor against RRP. This relationship is much more 
likely to reflect the client’s adherence to the contraceptive method, rather than the effectiveness 
of the contraceptive methods, themselves. Templemen et al. (2000), likewise, found that the OCP 
had a significantly lower retention rate and had a significantly greater effect on the chances on 
RRP than did the Depo injection. Barrier methods of contraception, such as condoms, 
spermicide, and female condoms, have a small and marginally significant hazardous effect on 
RRP. This may reflect inconsistency in using condoms during sex or condom breakage. 
6.4 Psychosocial Factors of RRP 
For Aim 1, the most protective factor from a shorter IPI was found to be a client’s 
unplanned index pregnancy. In both analyses, unplanned index pregnancies predicted a lower 
hazard rate than pregnancies that were planned. This is in contrast to another study that did not 
consider postpartum contraceptives, but found that previously unintended pregnancies were 
highly predictive of a RRP (Gemmill & Lindberg, 2013). It suggests that the clients in this 
sample who did not plan to get pregnant were more careful to prevent another pregnancy that 
they likely could not afford. 
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Physical abuse during and postpartum depression both have a hazardous effect on RRP in 
the Aim 1 analysis. Interestingly, but not surprisingly, the two variables interacted with each 
other in the Aim 2 analysis. These findings agree with Patchen et al. (2009) that women with 
trauma and mental health issues are at higher risk of RRP. The perinatal woman’s relationship 
with the father or a male strongly affects her psychosocial health. Both financial and emotional 
support are crucial for the mother and the child; lack thereof creates a multitude of challenges for 
the mother; and, on the other end of the spectrum, abuse is obviously detrimental to the mother’s 
health. 
6.5 Age as a Predictor of Rapid Repeat Pregnancy 
 In contrast with other research findings, the age of the client at her index pregnancy did 
not have a statistically significant effect on time to RRP in the Aim 1 analysis. The effect itself, 
although increasingly protective with older clients, was miniscule. Only when adjusting for the 
time-varying contraceptive method use as well as the interaction of LARC with time did the 
protective effect of age become statistically significant, but it was still very small in magnitude. 
This may be due to the age distribution of the final sample, which consists mostly of younger 
clients (< 23 years old). The restriction of the age range likely prevented the model from 
detecting the effect that exists in other research. 
6.6 Conclusion 
As described in the LCHS program strategy, the federal Healthy Start program sets a 
benchmark goal that, out of the clients who have a repeat pregnancy while enrolled, 70% have an 
IPI longer than 18 months. Five clients were censored at 24 months, meaning that they 
experienced a repeat pregnancy, but it was not a RRP as defined for the study. Out of the 107 
total repeat pregnancies in the final sample, 21 (19.63%) did not conceive again within 18 
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months. Out of the total study population that experienced a repeat pregnancy (n = 145), 
including clients who were excluded due to missing covariates, 24 (16.55%) did not conceive 
again within 18 months. Clearly, far too many women are experiencing repeat pregnancies too 
soon in their postpartum period, even with increased effort to distribute more postpartum 
contraception.  
 The current study has important limitations. It excluded all observations with missing 
covariates. Several of the t-tests and chi-square tests of association between the excluded sample 
and the included sample were significant, indicating that the missing observations were not 
missing completely at random. The final sample included a greater proportion of clients who 
received postpartum contraceptive methods and used them over a longer period of time. These 
clients had a more complete assessment, at least with the chosen covariates, and may have had 
more comprehensive case management and access to contraception. The rate of RRP in the final 
sample, however, was significantly higher than the rate of RRP in the excluded clients. 
Nonetheless, the mean IPI of the excluded clients was about two months shorter than that of the 
final sample. Since the vast majority of clients were censored prior to 24 months postpartum, this 
may suggest that more clients who had missing covariates dropped services with LCHS before 
the program could record a RRP for the client.  These differences between the final sample and 
the excluded sample elucidate a strong likelihood of bias in the effect of postpartum 
contraception that may not be generalizable to the study population. Finally, in calculating the 
survival rates over time for each covariate, we were not able to capture any interactions with 
time, as the Cox model cannot estimate survival in the future. Thus, the effects of receiving the 
Depo injection at discharge in Aim 1 and the effect of receiving a LARC in Aim 2 were not 
Postpartum Contraception and Rapid Repeat Pregnancies53 
 
accurately captured for all lengths of time (6, 12 and 18 months), but rather each variable was 
assumed (incorrectly) to have proportional hazards in their respective adjusted models. 
Critical questions emerged during the analysis that requires future research. Next steps 
include testing Depo at discharge and other baseline risk factors on predicting continued use or 
ever-use of the different contraceptive methods to determine that aspect of postpartum 
contraceptive use, since the issue is in the client’s adherence instead of the biological mechanism 
of the contraceptives. As noted in the literature review, adolescents who received a 
comprehensive counseling service were less likely to experience an RRP (Barnet et al., 2009; 
Patchen et al., 2013). LCHS also tracks each counseling and educational service that a client 
attends. Future research should also take into account the effectiveness of attending the services 
that are related to family planning and contraceptive use on time to RRP. 
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